Original Research

The Economic Implications of Hyperkalemia in a Medicaid Managed Care Population

Nihar R Desai, MD, MPH, Pamala Reed, DrPH, MPH, Paula J Alvarez, RPh, MBA, MPH, Jeanene Fogli, PhD, RD, Steven D Woods, PharmD, Mary Kay Owens, RPh, CPh

November 2019 Vol 12, No 7 - Original Research

Stakeholder Perspective

The Impact of Quality Care on a Medicaid Population with Hyperkalemia

by Byron C. Scott, MD, MBA

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States

Michael C. Runken, PharmD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD

October 2019 Vol 12, No 6 - Business, Original Research

Stakeholder Perspective

Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?

by Gary M. Owens, MD

Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer

Krishna Tangirala, MPH, Sreevalsa Appukkuttan, MPH, MBBS, Stacey Simmons, MD

October 2019 Vol 12, No 6 - Business, Original Research

Stakeholder Perspective

The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs

Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus

Pragya Rai, MS, Nilanjana Dwibedi, PhD, Mazhgan Rowneki, MPH, Drew A. Helmer, MD, MS, Usha Sambamoorthi, PhD

September 2019 Vol 12, No 5 - Clinical, Original Research

Stakeholder Perspective

Impact of DPP-4 Inhibitors on Joint Pain in Older Veterans with Diabetes

by Priya Nileshwar, DO, Quang T. Nguyen, DO, FACE, FTOS

Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing

Joshua A. Roth, PhD, MHA, Theo deVos, PhD, Scott D. Ramsey, MD, PhD

September 2019 Vol 12, No 5 - Business, Original Research

Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models

Thomas Lodise, PhD, PharmD, Kenneth LaPensee, PhD, MPH

June/July 2019 Vol 12, No 4 - Business, Original Research

Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation

William P. Glasheen, PhD, Tristan Cordier, MPH, Rajiv Gumpina, MS, Gilbert S. Haugh, MS, Jared Davis, MD, MBA, Andrew Renda, MD, MPH

June/July 2019 Vol 12, No 4 - Clinical, Original Research

Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults

Aisha Vadhariya, PhD Candidate, Marc L. Fleming, PhD, MPH, RPh, Michael L. Johnson, PhD, E. James Essien, MD, DrPH, Omar Serna, PharmD, BCACP, Tara Esse, PharmD, BCACP, Jeannie Choi, PharmD, Susan H. Boklage, MS, MPH, Susan M. Abughosh, PhD

June/July 2019 Vol 12, No 4 - Clinical, Original Research

Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis

Jeffrey T. Guptill, MD, MA, MHS, Michael C. Runken, PharmD, Michael Eaddy, PharmD, PhD, Orsolya Lunacsek, PhD, Rupali M. Fuldeore, MS

May 2019 Vol 12, No 3 - Clinical, Original Research

Stakeholder Perspective

Enhanced Understanding and Management of Rare Diseases Can Reduce Costs, Improve Clinical Outcomes

by James T. Kenney, RPh, MBA

Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases

Lonnie Wen, RPh, PhD, Adriana Valderrama, PhD, Mary E. Costantino, PhD, Stacey Simmons, MD

May 2019 Vol 12, No 3 - Clinical, Original Research

12 3 4 5 6 7 8 »End

Page 1 of 8
Results 1 - 10 of 72